|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||124.38 - 125.46|
|52 Week Range||99.60 - 133.00|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.35%|
In May 2017, Regeneron Pharmaceuticals (REGN) and Inovio Pharmaceuticals (INO) entered into an agreement for an immuno-oncology clinical study.
Major players in the biotech space reported their second quarter 2017 results.
Betting on ETFs with the winning combination of stocks that have a positive Earnings ESP and a favorable Zacks Rank #1, 2 or 3 would lead to profits in investor portfolios.